• Caspase-3 Colorimetric Assay Kit: Workflow Guide

  2026-08-25

  The Caspase-3 Colorimetric Assay Kit measures DEVD-dependent caspase-3 activity by detecting p-nitroaniline released from the DEVD-pNA substrate. It is suitable for comparative apoptosis studies and caspase activity measurement in biological lysates, but it should not be used alone to prove apoptosis, define upstream pathway activation, or support a clinical diagnosis.

• HBTU Workflows for Bioluminescent Peptide Probes

  2026-08-24

  HBTU streamlines the solid-phase synthesis of reporter-bearing peptides, including constructs designed for immunoproteasome activity assays. This guide connects coupling chemistry with plate-reader implementation, emphasizing practical parameter selection, reproducibility, and troubleshooting rather than unsupported translational claims.

• HyperScript RT SuperMix for qPCR Workflow

  2026-08-24

  Build a reproducible two-step qRT-PCR workflow for lncRNA, mRNA, and challenging RNA samples using a thermally stable reverse transcriptase and balanced primer blend. The approach translates the IPCRL1 myocardial ischemia/reperfusion study into practical cDNA synthesis, assay controls, and troubleshooting decisions for low-input gene expression analysis.

• D-Luciferin Sodium Salt for CAR-M Imaging

  2026-08-23

  D-Luciferin sodium salt converts firefly luciferase activity into a dynamic readout for CAR macrophage research. This article explains how to interpret ATP-dependent light signals alongside tumor burden, cellular energy metabolism, and immune-state data.

• Rocilinostat (ACY-1215) Research Workflows

  2026-08-22

  Rocilinostat (ACY-1215) enables selective HDAC6 perturbation for α-tubulin acetylation, multiple myeloma viability, and combination-response studies. This workflow also shows how to extend HDAC6-focused assays into exploratory primary-cilia research without overstating the SMPD4 evidence.

• Enzymatic Isolation Shapes Colorectal Cancer Organoids

  2026-08-22

  This study systematically compares TrypLE, Trypsin–EDTA, Collagenase, and Hyaluronidase for establishing patient-derived colorectal cancer organoids. Its key finding is that Collagenase and Hyaluronidase generally outperform the protease-based approaches for tissue dissociation, stem-cell marker recovery, and organoid expansion, while TrypLE and Trypsin–EDTA better preserve viability but release fewer cells.

• Latrunculin A for Mechanobiology Assay Design

  2026-08-21

  Latrunculin A provides a reversible inhibitor of actin assembly for separating cytoskeletal execution from upstream mechanical sensing. This article develops an assay-design framework linking G-actin sequestration to stiffness-dependent axon growth, morphology, and motility measurements.

• Staurosporine Workflows for Kinase and Apoptosis Studies

  2026-08-20

  Learn how to use Staurosporine as a controlled kinase-perturbation tool for apoptosis, signaling, motility, and angiogenesis assays. This workflow emphasizes DMSO handling, dose–response design, orthogonal validation, and interpretation of metastasis-related phenotypes.

• MCC950 sodium in Neuroinflammation Workflows

  2026-08-20

  MCC950 sodium enables selective NLRP3 inflammasome inhibition across macrophage, neuroinflammation, and autoimmune disease workflows. This guide translates recent astrocyte research into practical assay design, controls, optimization steps, and troubleshooting strategies.

• Mapping SLC2A5 in PCNSL Tissue with Assay Rigor

  2026-08-19

  Single-cell evidence identifies SLC2A5-mediated fructose metabolism as a potential vulnerability in primary central nervous system lymphoma. This article translates that mechanistic insight into a disciplined tissue-assay strategy, showing how a Primary Antibody Dilution Buffer can support reproducible immunohistochemistry, immunocytochemistry, and antibody-based in situ hybridization while keeping workflow recommendations distinct from published biological evidence.

• Extracellular Vesicle Transfer of Immunoproteasomes

  2026-08-19

  A 2026 study provides evidence that non-constitutive proteasomes, including β5i-containing complexes, can move between cells inside extracellular vesicles. Using engineered donor cells, orthogonal vesicle-isolation methods, particle analysis, microscopy, and recipient-cell assays, the work establishes a framework for studying proteasome trafficking beyond intracellular degradation.

• Forskolin in Pancreatic Ductal Organoid Assays

  2026-08-18

  Forskolin is an adenylate cyclase activator that can turn cAMP signaling into a controlled perturbation variable in pancreatic ductal organoid research. This article explains how to interpret its use alongside the small-molecule strategy reported for high-efficiency organoid generation, with practical guidance for lineage, viability, and functional readouts.

• ML133 HCl: Selective Kir2.1 Workflows

  2026-08-18

  ML133 HCl is a selective potassium channel inhibitor for connecting Kir2.1 activity with pulmonary vascular remodeling, cell migration, and signaling. This workflow-focused guide covers dosing, assay design, selectivity controls, and troubleshooting for cardiovascular ion channel research.

• Ciclesonide Workflows for Asthma Research

  2026-08-17

  Ciclesonide supports reproducible airway inflammation studies by combining measurable prodrug activation with potent desisobutyryl-ciclesonide signaling. This guide translates its chemistry into cell-based, pharmacology, and exploratory ERAD workflows while clearly separating established respiratory evidence from emerging targeted-degradation concepts.

• Monomethyl Auristatin E: A State-Aware ADC Payload

  2026-08-17

  Monomethyl auristatin E (MMAE) is more than a potent ADC cytotoxin: its performance depends on target delivery, intracellular release, and tumor-cell state. This article connects MMAE assay design with cancer plasticity biology while defining practical controls and translational limits.

8071 records 1/539 page Next 12345 下5页 Last page